← Evidence map

ArticleTherapeutic advances in medical oncology2013

Standard-dose tegafur-uracil (UFT) is not a safe alternative in partial dihydropyrimidine dehydrogenase-deficient patients.

Maarten J Deenen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2013
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 23323150